ArcticZymes Technologies ASA (LTS:0DRV) Beneish M-Score: -2.91 (As of Jun. 25, 2026)


LTS:0DRV ArcticZymes Technologies ASA LTS:0DRV
76 GF Score
Price kr20.90
GF Value kr23.81
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is ArcticZymes Technologies ASA Beneish M-Score?

ArcticZymes Technologies ASA LTS:0DRV 76 Beneish M-Score is -2.91 as of Jun. 25, 2026. GuruFocus rates LTS:0DRV with a GF Score™ of 76/100 and a GF Value™ of kr23.81 (Modestly Undervalued). The stock has 1 warning sign investors should review. Among 831 Biotechnology companies, ArcticZymes Technologies ASA ranks better than 71.6% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.91 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for ArcticZymes Technologies ASA's Beneish M-Score or its related term are showing as below:

LTS:0DRV' s Beneish M-Score Range Over the Past 10 Years
Min: -3.26   Med: -2.45   Max: -0.27
Current: -2.91

During the past 13 years, the highest Beneish M-Score of ArcticZymes Technologies ASA was -0.27. The lowest was -3.26. And the median was -2.45.


ArcticZymes Technologies ASA Beneish M-Score Historical Data

* Premium members only.

The historical data trend for ArcticZymes Technologies ASA's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ArcticZymes Technologies ASA Beneish M-Score Chart

ArcticZymes Technologies ASA Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.00 -3.26 -2.25 -1.65 -2.91

ArcticZymes Technologies ASA Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -2.91 0.00

LTS:0DRV vs VRTX, REGN, ALNY: Beneish M-Score Comparison

For the Biotechnology subindustry, ArcticZymes Technologies ASA's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ArcticZymes Technologies ASA Beneish M-Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ArcticZymes Technologies ASA's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where ArcticZymes Technologies ASA's Beneish M-Score falls into.


LTS:0DRV
76GF Score
ArcticZymes Technologies ASA LTS:0DRV
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ArcticZymes Technologies ASA Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of ArcticZymes Technologies ASA for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9879+0.528 * 0.9852+0.404 * 0.9267+0.892 * 1.0792+0.115 * 0.6508
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 2.1042+4.679 * -0.044468-0.327 * 1.043
=-2.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec25) TTM:Last Year (Dec24) TTM:
Total Receivables was kr21.9 Mil.
Revenue was kr112.6 Mil.
Gross Profit was kr107.8 Mil.
Total Current Assets was kr307.7 Mil.
Total Assets was kr361.3 Mil.
Property, Plant and Equipment(Net PPE) was kr16.8 Mil.
Depreciation, Depletion and Amortization(DDA) was kr9.2 Mil.
Selling, General, & Admin. Expense(SGA) was kr1.8 Mil.
Total Current Liabilities was kr18.8 Mil.
Long-Term Debt & Capital Lease Obligation was kr4.2 Mil.
Net Income was kr9.7 Mil.
Gross Profit was kr0.0 Mil.
Cash Flow from Operations was kr25.8 Mil.
Total Receivables was kr20.5 Mil.
Revenue was kr104.4 Mil.
Gross Profit was kr98.4 Mil.
Total Current Assets was kr285.2 Mil.
Total Assets was kr345.3 Mil.
Property, Plant and Equipment(Net PPE) was kr22.1 Mil.
Depreciation, Depletion and Amortization(DDA) was kr6.6 Mil.
Selling, General, & Admin. Expense(SGA) was kr0.8 Mil.
Total Current Liabilities was kr16.7 Mil.
Long-Term Debt & Capital Lease Obligation was kr4.4 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(21.883 / 112.618) / (20.525 / 104.352)
=0.194312 / 0.19669
=0.9879

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(98.369 / 104.352) / (107.752 / 112.618)
=0.942665 / 0.956792
=0.9852

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (307.669 + 16.779) / 361.268) / (1 - (285.227 + 22.071) / 345.272)
=0.101919 / 0.109983
=0.9267

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=112.618 / 104.352
=1.0792

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(6.581 / (6.581 + 22.071)) / (9.152 / (9.152 + 16.779))
=0.229687 / 0.352937
=0.6508

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1.828 / 112.618) / (0.805 / 104.352)
=0.016232 / 0.007714
=2.1042

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((4.155 + 18.789) / 361.268) / ((4.364 + 16.661) / 345.272)
=0.06351 / 0.060894
=1.043

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(9.738 - 0 - 25.803) / 361.268
=-0.044468

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

ArcticZymes Technologies ASA has a M-score of -2.91 suggests that the company is unlikely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -2.91 mean?
ArcticZymes Technologies ASA (LTS:0DRV) has a Beneish M-Score of -2.91 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on ArcticZymes Technologies ASA and its competitors. According to the industry distribution chart, ArcticZymes Technologies ASA ranks #236 out of 831 companies in the Biotechnology industry, placing it in the top 28.4%.
Is ArcticZymes Technologies ASA's Beneish M-Score too high?
ArcticZymes Technologies ASA's current Beneish M-Score is -2.91. Based on the distribution chart, ArcticZymes Technologies ASA ranks #236 out of 831 companies in the Biotechnology industry, which is above the industry midpoint. Overall, ArcticZymes Technologies ASA has a GF Score™ of 76/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ArcticZymes Technologies ASA's Beneish M-Score compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, ArcticZymes Technologies ASA ranks #236 out of 831 companies for Beneish M-Score. This puts ArcticZymes Technologies ASA in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Biotechnology company?
A good Beneish M-Score depends on the Biotechnology industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on ArcticZymes Technologies ASA and its competitors. ArcticZymes Technologies ASA's current Beneish M-Score is -2.91. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ArcticZymes Technologies ASA stock overvalued right now?
Based on GuruFocus' analysis, ArcticZymes Technologies ASA (LTS:0DRV) is currently considered Modestly Undervalued. The stock's GF Value™ is kr23.81, compared to a current price of kr20.90 — trading 12.2% below its estimated fair value. The current Beneish M-Score is -2.91. ArcticZymes Technologies ASA's overall GF Score™ is 76/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For ArcticZymes Technologies ASA (LTS:0DRV), the current Beneish M-Score is -2.91 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ArcticZymes Technologies ASA (LTS:0DRV) Overvalued in 2026?

Based on GuruFocus' analysis, ArcticZymes Technologies ASA stock appears to be undervalued. The current stock price of kr20.90 is trading 12.2% below its estimated GF Value™ of kr23.81. GuruFocus considers ArcticZymes Technologies ASA to be Modestly Undervalued.

Key valuation signals for LTS:0DRV:

  • Beneish M-Score: -2.91
  • GF Value™: kr23.81 vs. price of kr20.90 (12.2% below fair value)
  • GF Score™: 76/100 with 1 warning sign

No single metric tells the full story. See the LTS:0DRV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


ArcticZymes Technologies ASA Business Description

Other Exchanges BIOTECO:SwedenAZT:Norway
Address Sykehusveien 23, Tromso, NOR, 9294
ArcticZymes Technologies ASA is a biotechnology company. The company is engaged in developing, producing, and marketing immune-modulating beta-glucans and novel recombinant enzymes for use in molecular research, In Vitro Diagnostics (IVD) and biomanufacturing. The company's products include Woulgan wound gel, Feed Ingredient (M-Glucan), Nutraceuticals (M-Gard), Recombinant enzymes, and others. The company reports in two operating segments, Enzymes and Corporate. Geographically, it derives a majority of revenue from the USA followed by Lithuania, Norway, Germany, France, Italy, UK, Other countries in Europe, and Rest of world.
76GF Score

Get the complete analysis for LTS:0DRV

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr20.90
Price
kr23.81
GF Value